Phase II Study Exploring Five Fractions of Post-operative Radiation Therapy in Head and Neck Cancer (Accelerate)
The Accelerate Trial: Phase II Study Exploring Five Fractions of Accelerated Hypofractionated Post-operative Radiation Therapy in Head and Neck Cancer
Sponsor: All India Institute of Medical Sciences
A NA clinical study on Head and Neck Cancer, this trial is ongoing. The trial is conducted by All India Institute of Medical Sciences and has accumulated 5 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
5 versions recorded-
Feb 2026 — Present [monthly]
Unknown NA
Status: Not Yet Recruiting → Unknown
-
Jul 2025 — Feb 2026 [monthly]
Not Yet Recruiting NA
-
Sep 2024 — Jul 2025 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
Jan 2023 — Jul 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- All India Institute of Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .